159 related articles for article (PubMed ID: 36925699)
1. Brain-targeted exosome-mimetic cell membrane nanovesicles with therapeutic oligonucleotides elicit anti-tumor effects in glioblastoma animal models.
Lee Y; Kim M; Ha J; Lee M
Bioeng Transl Med; 2023 Mar; 8(2):e10426. PubMed ID: 36925699
[TBL] [Abstract][Full Text] [Related]
2. Antisense-oligonucleotide co-micelles with tumor targeting peptides elicit therapeutic effects by inhibiting microRNA-21 in the glioblastoma animal models.
Lee Y; Ha J; Kim M; Kang S; Kang M; Lee M
J Adv Res; 2023 Nov; 53():249-260. PubMed ID: 36632887
[TBL] [Abstract][Full Text] [Related]
3. Systemic delivery of microRNA-21 antisense oligonucleotides to the brain using T7-peptide decorated exosomes.
Kim G; Kim M; Lee Y; Byun JW; Hwang DW; Lee M
J Control Release; 2020 Jan; 317():273-281. PubMed ID: 31730913
[TBL] [Abstract][Full Text] [Related]
4. Programmable DNA Scaffolds Enable Orthogonal Engineering of Cell Membrane-Based Nanovesicles for Therapeutic Development.
Li W; Liu S; Wang Z; Gou L; Ou Y; Zhu X; Zhou Y; Zhang T; Liu J; Zheng X; Berggren PO; Liu J; Zheng X
Nano Lett; 2024 Jun; ():. PubMed ID: 38856668
[TBL] [Abstract][Full Text] [Related]
5. Intranasal delivery of targeted polyfunctional gold-iron oxide nanoparticles loaded with therapeutic microRNAs for combined theranostic multimodality imaging and presensitization of glioblastoma to temozolomide.
Sukumar UK; Bose RJC; Malhotra M; Babikir HA; Afjei R; Robinson E; Zeng Y; Chang E; Habte F; Sinclair R; Gambhir SS; Massoud TF; Paulmurugan R
Biomaterials; 2019 Oct; 218():119342. PubMed ID: 31326657
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol-loaded biomimetic macrophage membrane vesicles against post-traumatic stress disorder assisted by ultrasound.
Li Q; Wang C; Hu J; Jiao W; Tang Z; Song X; Wu Y; Dai J; Gao P; Du L; Jin Y
Int J Pharm; 2023 Apr; 637():122872. PubMed ID: 36958611
[TBL] [Abstract][Full Text] [Related]
7. Kill two birds with one stone: Engineered exosome-mediated delivery of cholesterol modified YY1-siRNA enhances chemoradiotherapy sensitivity of glioblastoma.
Liu X; Cao Z; Liu N; Gao G; Du M; Wang Y; Cheng B; Zhu M; Jia B; Pan L; Zhang W; Jiang Y; He W; Xu L; Zhang W; An Q; Guo Q; Gu J
Front Pharmacol; 2022; 13():975291. PubMed ID: 36059990
[TBL] [Abstract][Full Text] [Related]
8. Development of a Targeted SN-38-Conjugate for the Treatment of Glioblastoma.
Bataille Backer P; Adekiya TA; Kim Y; Reid TR; Thomas M; Adesina SK
ACS Omega; 2024 Jan; 9(2):2615-2628. PubMed ID: 38250376
[TBL] [Abstract][Full Text] [Related]
9. Polymeric nanoparticle mediated inhibition of miR-21 with enhanced miR-124 expression for combinatorial glioblastoma therapy.
Liu Y; Zheng M; Jiao M; Yan C; Xu S; Du Q; Morsch M; Yin J; Shi B
Biomaterials; 2021 Sep; 276():121036. PubMed ID: 34329919
[TBL] [Abstract][Full Text] [Related]
10. A stabilized retro-inverso peptide ligand of transferrin receptor for enhanced liposome-based hepatocellular carcinoma-targeted drug delivery.
Tang J; Wang Q; Yu Q; Qiu Y; Mei L; Wan D; Wang X; Li M; He Q
Acta Biomater; 2019 Jan; 83():379-389. PubMed ID: 30395963
[TBL] [Abstract][Full Text] [Related]
11. A curcumin-loaded polymeric micelle as a carrier of a microRNA-21 antisense-oligonucleotide for enhanced anti-tumor effects in a glioblastoma animal model.
Tan X; Kim G; Lee D; Oh J; Kim M; Piao C; Lee J; Lee MS; Jeong JH; Lee M
Biomater Sci; 2018 Jan; 6(2):407-417. PubMed ID: 29340361
[TBL] [Abstract][Full Text] [Related]
12. A simple self-assembly nanomicelle based on brain tumor-targeting peptide-mediated siRNA delivery for glioma immunotherapy via intranasal administration.
Tang L; Zhang R; Wang Y; Zhang X; Yang Y; Zhao B; Yang L
Acta Biomater; 2023 Jan; 155():521-537. PubMed ID: 36384220
[TBL] [Abstract][Full Text] [Related]
13. RNA Nanoparticle-Based Targeted Therapy for Glioblastoma through Inhibition of Oncogenic miR-21.
Lee TJ; Yoo JY; Shu D; Li H; Zhang J; Yu JG; Jaime-Ramirez AC; Acunzo M; Romano G; Cui R; Sun HL; Luo Z; Old M; Kaur B; Guo P; Croce CM
Mol Ther; 2017 Jul; 25(7):1544-1555. PubMed ID: 28109960
[TBL] [Abstract][Full Text] [Related]
14. Comparison of three synthetic transferrin mimetic small peptides to promote the blood-brain barrier penetration of vincristine liposomes for improved glioma targeted therapy.
Mojarad-Jabali S; Farshbaf M; Hemmati S; Sarfraz M; Motasadizadeh H; Shahbazi Mojarrad J; Atyabi F; Zakeri-Milani P; Valizadeh H
Int J Pharm; 2022 Feb; 613():121395. PubMed ID: 34933080
[TBL] [Abstract][Full Text] [Related]
15. Anti-cancer effect of R3V6 peptide-mediated delivery of an anti-microRNA-21 antisense-oligodeoxynucleotide in a glioblastoma animal model.
Oh B; Song H; Lee D; Oh J; Kim G; Ihm SH; Lee M
J Drug Target; 2017 Feb; 25(2):132-139. PubMed ID: 27355932
[TBL] [Abstract][Full Text] [Related]
16. MiRNA-21 silencing mediated by tumor-targeted nanoparticles combined with sunitinib: A new multimodal gene therapy approach for glioblastoma.
Costa PM; Cardoso AL; Custódia C; Cunha P; Pereira de Almeida L; Pedroso de Lima MC
J Control Release; 2015 Jun; 207():31-9. PubMed ID: 25861727
[TBL] [Abstract][Full Text] [Related]
17. Cell Membrane-Derived Nanovehicles for Targeted Therapy of Ischemic Stroke: From Construction to Application.
Hao C; Sha M; Ye Y; Wang C
Pharmaceutics; 2023 Dec; 16(1):. PubMed ID: 38276484
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive transferrin targeted nanovesicles sensitize resistant glioblastoma multiforme tumors and improve survival in orthotopic mouse models.
Sandbhor P; Goda J; Mohanty B; Chaudhari P; Dutt S; Banerjee R
Nanoscale; 2021 Dec; 14(1):108-126. PubMed ID: 34897360
[TBL] [Abstract][Full Text] [Related]
19. Brain tumor-targeted therapy by systemic delivery of siRNA with Transferrin receptor-mediated core-shell nanoparticles.
Wei L; Guo XY; Yang T; Yu MZ; Chen DW; Wang JC
Int J Pharm; 2016 Aug; 510(1):394-405. PubMed ID: 27374198
[TBL] [Abstract][Full Text] [Related]
20. [Cell penetrating peptide TAT and brain tumor targeting peptide T7 dual modified liposome preparation and in vitro targeting evaluation].
Yuan DF; Zong TL; Gao HL; He Q
Yao Xue Xue Bao; 2015 Jan; 50(1):104-10. PubMed ID: 25924484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]